A detailed history of Schonfeld Strategic Advisors LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 2,223,308 shares of MRSN stock, worth $3.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,223,308
Previous 2,976,918 25.32%
Holding current value
$3.6 Million
Previous $5.98 Million 29.77%
% of portfolio
0.03%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.23 - $2.25 $926,940 - $1.7 Million
-753,610 Reduced 25.32%
2,223,308 $4.2 Million
Q2 2024

Aug 14, 2024

BUY
$2.0 - $4.45 $3.94 Million - $8.76 Million
1,968,260 Added 195.14%
2,976,918 $5.98 Million
Q1 2024

May 15, 2024

SELL
$2.16 - $5.94 $282,417 - $776,649
-130,749 Reduced 11.48%
1,008,658 $4.52 Million
Q4 2023

Feb 14, 2024

BUY
$1.11 - $2.34 $1.26 Million - $2.67 Million
1,139,407 New
1,139,407 $2.64 Million
Q2 2023

Aug 14, 2023

BUY
$3.08 - $9.55 $987,263 - $3.06 Million
320,540 New
320,540 $1.05 Million
Q3 2022

Nov 14, 2022

BUY
$4.63 - $8.0 $398,879 - $689,208
86,151 New
86,151 $583,000
Q2 2022

Aug 15, 2022

SELL
$2.84 - $5.0 $150,236 - $264,500
-52,900 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.74 - $6.63 $197,846 - $350,727
52,900 New
52,900 $211,000
Q3 2021

Nov 16, 2021

SELL
$8.56 - $14.47 $192,600 - $325,575
-22,500 Closed
0 $0
Q2 2021

Nov 16, 2021

SELL
$13.28 - $18.07 $203,184 - $276,471
-15,300 Reduced 40.48%
22,500 $306,000
Q2 2021

Aug 16, 2021

SELL
$13.28 - $18.07 $107,594 - $146,403
-8,102 Reduced 17.65%
37,800 $514,000
Q1 2021

May 17, 2021

SELL
$15.31 - $26.52 $1.64 Million - $2.85 Million
-107,435 Reduced 70.06%
45,902 $743,000
Q4 2020

Feb 16, 2021

BUY
$16.84 - $27.59 $1.02 Million - $1.67 Million
60,692 Added 65.51%
153,337 $4.08 Million
Q3 2020

Nov 16, 2020

BUY
$16.2 - $25.7 $699,969 - $1.11 Million
43,208 Added 87.4%
92,645 $2,000
Q2 2020

Aug 14, 2020

BUY
$5.24 - $23.4 $46,793 - $208,962
8,930 Added 22.05%
49,437 $1.16 Million
Q1 2020

May 15, 2020

BUY
$4.41 - $9.28 $132,330 - $278,464
30,007 Added 285.78%
40,507 $236,000
Q4 2019

Feb 14, 2020

BUY
$1.45 - $6.73 $15,225 - $70,665
10,500 New
10,500 $60,000
Q2 2018

Aug 14, 2018

SELL
$14.2 - $22.68 $148,347 - $236,937
-10,447 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$13.56 - $18.48 $141,661 - $193,060
10,447 New
10,447 $165,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $157M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.